Raymond J. Henley Iii

Array ( [id] => 3695678 [patent_doc_number] => 05661137 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Antacid pharmaceutical composition in the form of a suspension based on sucralfate gel' [patent_app_type] => 1 [patent_app_number] => 8/591647 [patent_app_country] => US [patent_app_date] => 1996-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2019 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/661/05661137.pdf [firstpage_image] =>[orig_patent_app_number] => 591647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729333 [patent_doc_number] => 05652249 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Method of treating depression' [patent_app_type] => 1 [patent_app_number] => 8/591610 [patent_app_country] => US [patent_app_date] => 1996-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3295 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652249.pdf [firstpage_image] =>[orig_patent_app_number] => 591610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3707061 [patent_doc_number] => 05654334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Analgesic use of N-L-.alpha.-aspartyl-L-phenylalanine 1-methyl ester' [patent_app_type] => 1 [patent_app_number] => 8/590409 [patent_app_country] => US [patent_app_date] => 1996-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6892 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654334.pdf [firstpage_image] =>[orig_patent_app_number] => 590409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3838183 [patent_doc_number] => 05846964 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Hepatitis C virus proliferation inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/586633 [patent_app_country] => US [patent_app_date] => 1996-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1938 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846964.pdf [firstpage_image] =>[orig_patent_app_number] => 586633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3851016 [patent_doc_number] => 05767112 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Muscle relaxant pharmaceutical compositions' [patent_app_type] => 1 [patent_app_number] => 8/586088 [patent_app_country] => US [patent_app_date] => 1996-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3167 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767112.pdf [firstpage_image] =>[orig_patent_app_number] => 586088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624817 [patent_doc_number] => 05612375 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Creatine beverage and producing process thereof' [patent_app_type] => 1 [patent_app_number] => 8/583963 [patent_app_country] => US [patent_app_date] => 1996-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2195 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612375.pdf [firstpage_image] =>[orig_patent_app_number] => 583963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688742 [patent_doc_number] => 05696149 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders' [patent_app_type] => 1 [patent_app_number] => 8/585012 [patent_app_country] => US [patent_app_date] => 1996-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2938 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696149.pdf [firstpage_image] =>[orig_patent_app_number] => 585012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3740647 [patent_doc_number] => 05753640 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome' [patent_app_type] => 1 [patent_app_number] => 8/580716 [patent_app_country] => US [patent_app_date] => 1995-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 14314 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753640.pdf [firstpage_image] =>[orig_patent_app_number] => 580716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662155 [patent_doc_number] => 05597585 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-28 [patent_title] => 'Vitamin/mineral composition' [patent_app_type] => 1 [patent_app_number] => 8/578284 [patent_app_country] => US [patent_app_date] => 1995-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2648 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/597/05597585.pdf [firstpage_image] =>[orig_patent_app_number] => 578284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770377 [patent_doc_number] => 05849729 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Use of hydrolyzed cocoa butter for percutaneous absorption' [patent_app_type] => 1 [patent_app_number] => 8/578455 [patent_app_country] => US [patent_app_date] => 1995-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11466 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849729.pdf [firstpage_image] =>[orig_patent_app_number] => 578455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3890800 [patent_doc_number] => 05834466 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Method for protecting of heart by limiting metabolic and ionic abnormalities developed during ischemia, following ischemia or resulting from ischemia' [patent_app_type] => 1 [patent_app_number] => 8/574899 [patent_app_country] => US [patent_app_date] => 1995-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 14097 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834466.pdf [firstpage_image] =>[orig_patent_app_number] => 574899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3723708 [patent_doc_number] => 05672590 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Pharmaceutical composition for immunomodulating and adjuvant treatment' [patent_app_type] => 1 [patent_app_number] => 8/564328 [patent_app_country] => US [patent_app_date] => 1995-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3528 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672590.pdf [firstpage_image] =>[orig_patent_app_number] => 564328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3843262 [patent_doc_number] => 05708021 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Debittered ranitidine preparation' [patent_app_type] => 1 [patent_app_number] => 8/574340 [patent_app_country] => US [patent_app_date] => 1995-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1853 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/708/05708021.pdf [firstpage_image] =>[orig_patent_app_number] => 574340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3732982 [patent_doc_number] => 05665767 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Crystalline cyclodextrin complexes of ranitidine hydrochloride, process for their preparation and pharmaceutical compositions containing the same' [patent_app_type] => 1 [patent_app_number] => 8/513779 [patent_app_country] => US [patent_app_date] => 1995-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 11 [patent_no_of_words] => 2641 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665767.pdf [firstpage_image] =>[orig_patent_app_number] => 513779 [rel_patent_id] =>[rel_patent_doc_number] =>)